Publicaciones en las que colabora con Pablo Mir Rivera (6)

2021

  1. Continuous intestinal infusion of levodopa-carbidopa in patients with advanced Parkinson's disease in Spain: Subanalysis by autonomous community

    Neurologia, Vol. 36, Núm. 2, pp. 101-111

  2. Present and future of parkinson’s disease in Spain: Parkinson-2030 delphi project

    Brain Sciences, Vol. 11, Núm. 8

  3. Spanish expert consensus on the use of safinamide in Parkinson's disease

    Neurologia, Vol. 36, Núm. 9, pp. 666-672

2019

  1. Impact of disease duration in effectiveness of treatment with levodopa-carbidopa intestinal gel and factors leading to discontinuation

    Journal of Parkinson's Disease, Vol. 9, Núm. 1, pp. 173-182

2016

  1. Long-term effectiveness of levodopa-carbidopa intestinal gel in 177 Spanish patients with advanced Parkinson's disease

    Neurodegenerative disease management, Vol. 6, Núm. 4, pp. 289-298

2009

  1. Neuroprotección en la enfermedad de parkinson: Análisis a través de la metodología de informadores clave

    Neurologia, Vol. 24, Núm. 2, pp. 113-124